A detailed history of Oak Family Advisors, LLC transactions in Neogenomics Inc stock. As of the latest transaction made, Oak Family Advisors, LLC holds 107,962 shares of NEO stock, worth $1.77 Million. This represents 0.5% of its overall portfolio holdings.

Number of Shares
107,962
Previous 109,095 1.04%
Holding current value
$1.77 Million
Previous $1.51 Million 5.22%
% of portfolio
0.5%
Previous 0.53%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 17, 2024

SELL
$13.4 - $17.73 $15,182 - $20,088
-1,133 Reduced 1.04%
107,962 $1.59 Million
Q2 2024

Jul 23, 2024

BUY
$13.01 - $15.77 $18,916 - $22,929
1,454 Added 1.35%
109,095 $1.51 Million
Q1 2024

Apr 24, 2024

BUY
$14.06 - $16.79 $107,741 - $128,661
7,663 Added 7.66%
107,641 $1.69 Million
Q4 2023

Jan 30, 2024

BUY
$11.67 - $20.73 $37,822 - $67,185
3,241 Added 3.35%
99,978 $1.62 Million
Q3 2023

Oct 20, 2023

SELL
$12.15 - $17.85 $18,723 - $27,506
-1,541 Reduced 1.57%
96,737 $1.19 Million
Q2 2023

Aug 02, 2023

SELL
$14.1 - $19.83 $16,468 - $23,161
-1,168 Reduced 1.17%
98,278 $1.58 Million
Q1 2023

May 01, 2023

SELL
$9.09 - $19.45 $15,889 - $33,998
-1,748 Reduced 1.73%
99,446 $1.73 Million
Q4 2022

Jan 27, 2023

BUY
$6.45 - $12.07 $12,216 - $22,860
1,894 Added 1.91%
101,194 $0
Q3 2022

Nov 10, 2022

BUY
$7.86 - $12.91 $84,070 - $138,085
10,696 Added 12.07%
99,300 $855,000
Q2 2022

Jul 29, 2022

BUY
$7.06 - $13.97 $41,759 - $82,632
5,915 Added 7.15%
88,604 $722,000
Q1 2022

May 03, 2022

BUY
$12.15 - $35.28 $298,513 - $866,794
24,569 Added 42.27%
82,689 $1.01 Million
Q4 2021

Feb 02, 2022

BUY
$30.49 - $48.49 $16,921 - $26,911
555 Added 0.96%
58,120 $1.98 Million
Q3 2021

Nov 10, 2021

BUY
$41.66 - $52.52 $2.4 Million - $3.02 Million
57,565 New
57,565 $2.78 Million

Others Institutions Holding NEO

About NEOGENOMICS INC


  • Ticker NEO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 125,796,000
  • Market Cap $2.06B
  • Description
  • NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...
More about NEO
Track This Portfolio

Track Oak Family Advisors, LLC Portfolio

Follow Oak Family Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Oak Family Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Oak Family Advisors, LLC with notifications on news.